Introduction {#S0001}
============

*Streptococcus pneumoniae* is a common cause of meningitis and pneumococcal meningitis (PM) accounts for 50% of bacterial meningitis globally.1,[@CIT0002] PM is also a common bacterial meningitis in China[@CIT0003] Most PM patients present with a headache, neck stiffness, and fever[@CIT0004] Culture of cerebrospinal fluid (CSF) obtained from a lumbar puncture should be performed to confirm the diagnosis of PM.

In spite of progress in diagnosis, antibiotic therapy strategies, and intensive care, PM is associated with a mortality rate of 6%--17% in high-income countries including US and some European countries.[@CIT0005]--[@CIT0008] However, in developing countries and regions such as sub-Saharan Africa, the mortality of PM patients has been reported to be as high as 73%.[@CIT0007],[@CIT0009]--[@CIT0013] Among surviving patients, 25%--63% suffer from long-term neurological sequelae,[@CIT0005],[@CIT0009],[@CIT0014],[@CIT0015] which significantly affect the quality of life of survivors.

Early identification of patients with poor prognosis contributes to individualized treatment and more aggressive therapeutic strategies. A series of clinical features, biochemical, and microbiological factors have been identified as prognostic factors in PM. The most important prognostic factors associated with mortality of PM patients include C-reactive protein,[@CIT0005] age,[@CIT0016],[@CIT0017] score on SOFA, Glasgow Score, severe hypoglycorrhachia,[@CIT0017] corticosteroid treatment,[@CIT0018] and glucose in CSF[@CIT0019] And the most important prognostic factors in relation to neurological handicaps seem to be hypoglycorrhachia,[@CIT0020]--[@CIT0024] shock, coma and convulsions on admission or during hospitalization,[@CIT0025] mechanical ventilation requirement, late diagnosis, ataxia, and steroid treatment[@CIT0026]

However, these studies are mainly performed in European and American countries and limited to a few research centers. Further multicenter research is required to verify the prognostic value of these factors and improve clinical management of PM patients in mainland China. The present study aimed to recruit pediatric PM patients retrospectively from multiple hospitals in mainland China and investigate the risk factors of complications as well as the prognostic factors of overall survival (OS) and neurological sequelae-free survival (SFS) in pediatric PM patients.

Methods {#S0002}
=======

Participants {#S0002-S2001}
------------

A multicenter retrospective study was performed to consecutively recruit pediatric PM patients between January 2013 to June 2018 from ten pediatric tertiary hospitals in eight regions in mainland China (Shanghai, Hangzhou, Wenzhou, Xi'an, Chongqing, Shenzhen, Shandong, and Kaifeng).

Patient inclusion and exclusion criteria {#S0002-S2002}
----------------------------------------

Inclusion criteria: 1) age less than 5 years; 2) compatible with PM diagnosis criteria. Exclusion criteria: 1) patients with known primary immunodeficiency (including humoral immunity disorders, T-cell and B-cell disorders, phagocytic disorders, and complement disorders) or known secondary immunodeficiency (including human immunodeficiency virus infection, nephrotic syndrome, diabetes, etc); 2) patients had no cranial computed tomography (CT) and magnetic resonance imaging (MRI) results. The diagnostic criteria of PM were as follows: 1) clinical signs and symptoms (bulging fontanelles, stiff or painful neck, vomiting, headache, persistent or recurrent fever, change in mental state, seizures, or focal neurologic signs) that comply with meningitis; 2) the results of CSF examination were abnormal (the white blood cell \[WBC\] count in CSF was more than 10×10^6^/L, in which the neutrophil should be dominant, or the glucose level in CSF was less than 2.78 mmol/L, or the protein level in CSF was more than 0.45 g/L; 3) positive blood culture for *S. pneumoniae* with positive DNA testing of *S. pneumoniae* in CSF, or positive CSF culture for *S. pneumoniae*.

Identification of S. pneumoniae isolates {#S0002-S2003}
----------------------------------------

*S. pneumoniae* isolate was identified by automatic bacterial identification system (VITEK Compact, France) or Optochin Discs (OXOID, UK) according to the National Guide to Clinical Laboratory Procedures.

Data collection {#S0002-S2004}
---------------

Case record forms were used to collect data of patients' history, symptoms and signs, laboratory and microbiological findings, clinical course, complications in hospital, vaccination status, treatment, clinical outcome, neurological deficits at discharge, and follow-up visits from the ten hospitals listed in the affiliations. Underlying predisposing factors, including asplenia, history of head trauma or neurosurgery in the past 3 months, anatomical or infectious otorhinolaryngologic disorders, and immunocompromised status, were recorded. Patients with an altered immune status owing to the use of immunosuppressive drugs or splenectomy, diabetes mellitus were considered immunocompromised. Consciousness of the patients was accessed by Glasgow Coma Scale and grouped into normal, decline in consciousness, and coma.

Follow-up {#S0002-S2005}
---------

PM patients were followed-up every month in the first year, and every 6 months thereafter. The last follow-up date was September 30, 2018. OS was calculated from the onset date to the time of death of any cause while SFS was calculated from the onset date to the time of neurological deficits or death of any cause. Assessment was performed by a senior, experienced physician. We called the families to come to hospital for a follow-up visit to complete pediatric exam with a potential neuropsychological assessment. A telephone-based interview was suggested to the families who could not come to hospital. Physical examination, Gesell Development Scale test (\<3 years and 10 months), Wechsler Intelligence Scale test (≥3 years and 10 months), and Behavior Questionnaire test (≥2 years) were performed. Neurological sequela was evaluated according to the patients' last results of brain MRI, brainstem auditory evoked potential (BAEP), auditory brainstem response, and visual acuity. Neurological deficits included seizures, hemiparesis, ataxia, hydrocephalus and subdural hydrops or empyema, psychomotor retardation, hearing impairment, and visual impairment. Psychomotor retardation was indicated if gross-motor functions (neck control, sitting, walking, running, etc), fine-motor functions (reaching, grasping, drawing, etc), and activities of daily living (toileting, dressing, eating, writing, etc) were affected. Hearing was considered as impaired when the better ear failed to detect a threshold of 40 dB. Visual impairment was noted if the routine ophthalmic examination results of vision, visual field, fundus oculi, and eye movement were abnormal.

Statistics {#S0002-S2006}
----------

Statistical analysis was performed using SPSS 19.0 software (IBM Corporation, Armonk, NY, USA) and GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA). Data were presented as count (%), or median (interquartile range \[IQR\]). X-title software was used to obtain the best optimal cut-off values of the continuous variables based on prognosis. Chi-squared test and logistic regression analysis were used to investigate the associations of clinical characteristics and laboratory parameters with complications. Kaplan-Meier curves with logrank test and Cox's proportional hazard regression were applied to assess the associations of clinical characteristics and laboratory parameters with prognosis. *P*-value \<0.05 was considered significant.

Results {#S0003}
=======

Baseline clinical characteristics {#S0003-S2001}
---------------------------------

Data from one hundred and sixty-one pediatric patients diagnosed with PM were collected from ten pediatric tertiary hospitals across China. Twenty-nine patients were excluded due to primary or secondary immunodeficiency, or age more than 5 years and 132 patients were finally included ([Figure 1](#F0001){ref-type="fig"}). As shown in [Table 1](#T0001){ref-type="table"}, of the 132 patients, 88 were male and 44 were female. The median age of the patients was 13 months. Lumbar puncture was performed in all patients. Seventy-sixcases had a positive CSF culture for *S. pneumoniae*, 31 cases had a positive blood culture for *S. pneumoniae* with a positive DNA testing of *S. pneumoniae* in CSF, and 25 cases had both positive CSF culture and positive blood culture for *S. pneumoniae*. All patients had signs of meningitis.Table 1Clinical baseline characteristics, laboratory findings, and neurological sequelae of patients with PMCharacteristicCases n (%)CharacteristicCases n (%)**Total**132(100)**SexNeurological findings on admission** Male88(66.7)Triad syndrome22(16.7) Female44(33.3)Abnormal mental status46(34.8)**Age**Coma20(15.2)Median age (IQR, months)13(28)Convulsions on admission49(37.1)≤28 months94(71.2)**Laboratory findings**\>28 months38(28.8)Positive CSF culture76(57.6)**Hospital stay**Positive blood culture31(23.5)Median time (IQR, days)22(18)Positive CSF and blood culture25(18.9)**Symptoms and signs on admission**WBCs in blood (median, IQR, ×10^9^/L)14.5(14.7)Headache33(25.0)Neutrophil proportion in blood (median, IQR, %)78.5(17.5)Nausea80(60.6)C-Reactive Protein (median, IQR, mg/L)95.8(111.1)Neck stiffness68(51.5)WBCs in CSF (median, IQR, ×10^6^/L)400.0(1756.0)Bulging fontanelles27(20.5)Neutrophil proportion in CSF (median, IQR, %)80.0(12.8)Fever129(97.7)Protein in CSF (median, IQR, g/L)1.4 (2.6)Septic shock7(5.3)Glucose in CSF (median, IQR, mmol/L)1.1 (1.9)Mechanical ventilation17(11.4)**Focal neurological deficits n=107**39(29.5)Multiple organ failure5(3.8)Hypophrenia or behavioral deficits18(13.6)Respiratory failure9(6.8)Aphasia17(12.9)**Predisposing factors^a^ n=34**34(25.8)Dyskinesia13(9.8)Recent or remote cerebral trauma11(8.3)Hearing impairment12(9.1)CSF leakage13(9.8)Hydrocephalus8(6.1)Previous history of meningitis6(4.5)Hemiparesis8(6.1)Intracranial structure malformation5(3.8)Cranial nerve palsies5(3.8)Previous intracranial surgery^b^4(3.0)Secondary epilepsy4(3.0)Craniotomy4(3.0)Quadriplegia3(2.3)**Concomitant diseases n=84**84(63.6)Subdural effusion or abscess2(1.5)Pneumonia49(37.1)Visual impairment2(1.5)Sinusitis22(16.7)Cerebellar ataxia1(0.8)Mastoiditis24(18.2)Hypothalamus ataxia1(0.8)Otitis5(3.8)Ear or intracranial abnormalities8(6.1)[^1] Figure 1Flowchart of pediatric pneumococcal meningitis (PM) patients\' inclusion.

An amount of 25.8% (34/132) of patients had predisposing factors for PM including cerebral trauma in eleven (8.3%), CSF leakage in 13 (9.8%), history of meningitis (ie, the patient had meningitis previously) in six (4.5%), intracranial structure malformation in five (3.8%), history of intracranial surgery in four (3.0%), and craniotomy in four (3.0%) ([Table 1](#T0001){ref-type="table"}). Eighty-four PM patients were combined with other concomitant diseases including pneumoniae, mastoiditis, sinusitis, otitis, and ear or intracranial abnormalities. Fever and vomiting were the most frequent symptoms and signs on admission (97.7% and 60.6%, respectively). The consciousness status was altered in 46 patients on admission, of which 20 (15.2%) were in a coma.

Laboratory examination results were collected from medical records before or at admission. The medians of WBC counts, protein level in CSF, and glucose level in CSF were 14.5×10^9^/L (IQR: 14.7×10^9^/L), 1.4 g/L (IQR: 2.6 g/L), and 1.1 mmol/L (IQR: 1.9 mmol/L), respectively.

Complications and follow-up {#S0003-S2002}
---------------------------

PM complications were found in 53.8% (71/132) of patients by cranial CT and MRI ([Table 2](#T0002){ref-type="table"}). Subdural effusion, sinusitis or otitis, cerebritis, cerebral edema, hydrocephalus, intracranial hemorrhage, and empyema or abscess were the most common abnormalities and present in 47 (35.6%), 35 (26.5%), 29 (22.0%), 22 (16.7%), 17 (12.9%), 15 (11.4%), and 12 (9.1%) patients, respectively. Forty-one patients were associated with more than one abnormality. Twenty-five patients (18.9%) died -- all during hospitalization. Nine died within 1 week and 16 patients died 1--4 weeks after admission. The predefined neurological sequelae were evaluated in the 107 survivors during follow-up and identified in 39 patients. Hypophrenia or behavioral deficits, aphasia, dyskinesia, hearing impairment, and hydrocephalus were common focal neurological sequelae and present in 18 (13.6%), 17 (12.9%), 13 (9.8%), 12 (9.1%), and 8 (6.1%) patients of the 107 survivors, respectively ([Table 1](#T0001){ref-type="table"}).Table 2Complications of 132 pediatric pneumococcal meningitis patients on admission and during hospitalization examined by cranial computed tomography (CT) or magnetic resonance imaging (MRI) forCharacteristicPatients n (%)^a^Total number of abnormalities^b^71(53.8) Subdural effusion47(35.6) Sinusitis or otitis35(26.5) Cerebritis29(22.0) Cerebral edema22(16.7) Hydrocephalus17(12.9) Intracranial hemorrhage15(11.4) Empyema or abscess12(9.1) Cerebral atrophy7(5.3) Skull fracture7(5.3) Cerebral hernia5(3.8) Brain infarction4(3.0) Arachnoid cyst3(2.3) Other abnormalities^c^7(5.3)[^2]

Associations of clinical findings and laboratory parameters with complications {#S0003-S2003}
------------------------------------------------------------------------------

Chi-squared test was used to investigate the associations of clinical findings and laboratory parameters with complications and the results suggested that age less than 28 months, visual impairment, convulsions on admission, lower WBCs in blood, and predisposing factors were associated with complications in pediatric PM patients ([Table 3](#T0003){ref-type="table"}). Further multivariate logistic regression analysis revealed that age less than 28 months (aOR=2.654, 95%CI=1.067--6.600, *P*=0.036) and lower WBCs in blood (aOR=3.169, 95%CI=1.395--7.202, *P*=0.006) were independent predictive factors for complications in pediatric PM patients ([Table 4](#T0004){ref-type="table"}).Table 3Associations of the clinical features with complications in pediatric PM patients analyzed by chi-squared testParametersSubgroupsComplicationsChi-squared*P*-valueNOYESSexMale21230.0610.805Female4048Age≤28 months)346013.247**0.000**\>28 months2711Duration of disease≤4 days37480.6910.406\>4 days2423Consciousness stateNormal44422.4880.288Decline in consciousness1016Coma713Convulsions on admissionNO46368.511**0.004**YES1535Respiratory failureNO56670.3390.560YES54MODSNO59680.0810.776YES23Mechanical ventilationNO56611.1290.288YES510Septic shock on admissionNO58670.0330.855YES34Adjuvant steroid therapyNO16180.0130.909YES4553Antibiotics treatmentEarly15121.1920.275Late4659WBCs in bloodHigh483611.104**0.001**Low1335WBCs in CSFHigh15180.0100.920Low4050Glucose in CSFHigh24280.0000.991Low3743Protein in CSFLow28381.5150.218High2925Predisposing factorsNO22126.301**0.012**YES3959Concomitant diseaseNO38460.0300.863YES2225[^3] Table 4Associations of the clinical features with complications in pediatric PM patients analyzed by multivariate logistic regressionParameters*P-*valueOR95%CIAge (≤28 months vs \>28 months)0.0362.6541.0676.600Convulsions on admission (YES vs NO)0.1561.8230.7954.181WBCs in blood (low vs high)0.0063.1691.3957.202Predisposing factors (YES vs NO)0.1501.9460.7854.825[^4]

Associations of clinical findings and laboratory parameters with accumulating OS {#S0003-S2004}
--------------------------------------------------------------------------------

Kaplan-Meier plot curves and univariate Cox's proportional hazard regression were used to investigate the associations of clinical findings and laboratory parameters with accumulating OS and the results suggested that female sex, age less than 28 months ([Figure 2A](#F0002){ref-type="fig"}), coma ([Figure 2B](#F0002){ref-type="fig"}), convulsions on admission, respiratory failure, multiple organ dysfunction syndrome (MODS) (omit RF), ventilation, septic shock, non-adjuvant steroid therapy ([Figure 2C](#F0002){ref-type="fig"}), and higher protein level in CSF were associated with shorter OS in pediatric PM patients ([Table 5](#T0005){ref-type="table"}). Further multivariate Cox's proportional hazard regression revealed that age less than 28 months (aHR=6.479, 95%CI=1.153--36.404, *P*=0.034), coma (aHR=9.808, 95%CI=2.802--34.323, *P*=0.000), and non-adjuvant steroid therapy (aHR=4.768 95%CI=1.946--11.678, *P*=0.001) were independent prognostic factors for poor OS in pediatric PM patients ([Table 5](#T0005){ref-type="table"}).Table 5Associations of the clinical features with accumulating OS in pediatric PM patients analyzed by Cox's proportional hazard regressionParametersUnivariate analysisMultivariate analysis*P-*valueHR95%CI*P-*valueHR95%CISex (female vs male)**0.010**2.8121.2766.1990.1891.7740.7544.171Age (≤28 months vs \>28 months)**0.028**5.0321.18621.346**0.034**6.4791.15336.404Duration of disease (\>4 days vs ≤4 days)0.1891.6920.7723.709Complications (YES vs NO)0.4730.7500.3421.645Consciousness state**0.0000.002**NormalRefRef.Decline in consciousness0.2022.0710.6786.3320.0792.9160.8829.643Coma**0.000**10.6414.32126.201**0.000**9.8082.80234.323Convulsions on admission (YES vs NO)**0.043**2.2581.0254.9760.2050.4420.1251.560Respiratory failure (YES vs NO)**0.000**8.9883.70521.8060.3961.9030.4318.401MODS (YES vs NO)**0.001**6.3632.17018.6590.3261.8080.5555.888Mechanical ventilation (YES vs NO)**0.000**5.7812.54713.1240.1942.5720.61910.683Septic shock on admission (YES vs NO)**0.000**14.4655.51937.9140.0533.9270.98315.693Adjuvant steroid therapy (NO vs YES)**0.000**4.4912.0369.906**0.001**4.7681.94611.678Antibiotics treatment (late vs early)0.5311.4080.4834.102WBCs in blood (low vs high)0.1741.7230.7863.776WBCs in CSF (low vs high)0.1442.0540.7825.399Glucose in CSF (low vs high)0.1471.9900.7855.049Protein in CSF (high vs low)**0.034**2.5361.0745.9840.9531.0390.2923.693Concomitant disease (YES vs NO)0.0652.5120.9436.696Predisposing factors (YES vs NO)0.7800.8830.3692.114[^5] Figure 2Associations of clinical characteristics with accumulating overall survival in pediatric pneumococcal meningitis (PM) patients were analyzed by Kaplan-Meier plot curves and logrank test. (**A**) age; (**B**) consciousness; (**C**) steroid therapy.

Correlation of clinical findings and laboratory parameters with accumulating SFS {#S0003-S2005}
--------------------------------------------------------------------------------

Associations of clinical findings and laboratory parameters with accumulating SFS were also explored. The Kaplan-Meier curves and univariate Cox's proportional hazard regression suggested that coma ([Figure 3A](#F0003){ref-type="fig"}), convulsions on admission, respiratory failure, MODS (omit RF), mechanical ventilation, septic shock on admission ([Figure 3B](#F0003){ref-type="fig"}), non-adjuvant steroid therapy, and lower glucose level in CSF ([Figure 3C](#F0003){ref-type="fig"}) were associated with shorter SFS ([Table 6](#T0006){ref-type="table"}). After adjusting the confounding factors, coma (aHR=5.841, 95%CI=2.652--12.864, *P*=0.000), septic shock on admission (aHR=2.949, 95%CI=1.049--8.290, *P*=0.040), and lower glucose level in CSF (aHR=2.523, 95%CI=1.336--4.765, *P*=0.004) were found to be independent prognostic factors for unfavorable SFS in multivariate analyses ([Table 6](#T0006){ref-type="table"}).Table 6Associations of the clinical features with accumulating SFS analyzed by Cox's proportional hazard regressionParametersUnivariate analysisMultivariate analysis*P-*valueHR95%CI*P-*valueHR95%CISex (female vs male)0.5211.1840.7061.985Age (≤28 months vs \>28 months)0.1811.4850.8322.650Duration of disease (\>4 days vs ≤4 days)0.0641.5930.9732.609Complications (YES vs NO)0.4571.2080.7351.984Consciousness state**0.0000.000** NormalRefRef Decline in consciousness0.0791.7350.9393.2070.0801.7890.9323.434 Coma**0.000**4.9712.7329.046**0.000**5.8412.65212.864Convulsions on admission (YES vs NO)**0.050**1.6381.0012.6830.9151.0340.5591.912Respiratory failure (YES vs NO)**0.000**4.3372.0379.2330.5661.4130.4334.607MODS (YES vs NO)**0.003**4.0411.59110.2600.2091.8680.7044.954Mechanical ventilation (YES vs NO)**0.008**2.4041.2524.6180.7831.1480.4303.060Septic shock on admission (YES vs NO)**0.000**5.4462.30712.858**0.040**2.9491.0498.290Adjuvant steroid therapy (NO vs YES)**0.030**1.7851.0583.0110.0551.7710.9893.173Antibiotics treatment (late vs early)0.4250.7940.4501.399WBCs in blood (low vs high)0.0591.6100.9822.641WBCs in CSF (low vs high)0.0621.6950.9742.950Glucose in CSF (low vs high)**0.004**2.3451.3044.217**0.004**2.5231.3364.765Protein in CSF (high vs low)0.3181.3010.7772.178Concomitant disease (YES vs NO)0.8481.0510.6331.744Predisposing factors (YES vs NO)0.9900.9970.5661.755[^6] Figure 3Associations of clinical characteristics and laboratory parameters with accumulating sequelae-free survival in pediatric pneumococcal meningitis (PM) patients were analyzed by Kaplan-Meier plot curves and logrank test. (**A**) Consciousness; (**B**) septic shock; (**C**) glucose in cerebrospinal fluid (CSF).

Discussion {#S0004}
==========

In the present multicenter study, we included 132 pediatric patients and revealed that the overall mortality of these patients was 18.9% and the rate of focal neurological sequelae 36.4%, which were higher than that observed in US or European populations.[@CIT0005]--[@CIT0008],[@CIT0017],[@CIT0025],[@CIT0027],[@CIT0028] A meta-analysis in 1993, including mainly US and European cohorts, revealed a mortality rate of 4.8%--8.1% and a neurological handicap rate of 16%--26% in pediatric PM patients.[@CIT0029] Another meta-analysis in 2014, performed in Latin American and Caribbean populations, suggested that the mortality rate of pediatric PM patents was 8.3%[@CIT0030] In developing countries and regions such as sub-Saharan Africa, the mortality of PM patients has been reported to be as high as 73%.[@CIT0007],[@CIT0009]--[@CIT0013] The mortality of pediatric PM patients in China was higher than US or European cohorts but lower than African cohorts. The higher mortality and neurological sequelae rates emphasized the need to identify early prognostic factors for pediatric PM patients.

Of the 132 pediatric PM patients in the study, meningitis-associated intracranial complications were found in 53.8% patients by cranial CT or MRI. The most common intracranial complications were subdural effusion, cerebritis, cerebral edema, and hydrocephalus. The prevalence of cerebritis and hydrocephalus in our study was higher than adult PM patients in previous study of[@CIT0031] The prevalence of concomitant diseases was 63.6% in our study and was similar to the results of previous reports.[@CIT0031]--[@CIT0034]

After multivariate analyses of the prognostic factors in predicting complications, OS, and SFS outcomes in pediatric PM patients, we identified that age less than 28 months was associated with complications (aOR=2.654, 95%CI=1.067--6.600, *P*=0.036) and short OS (aHR=6.479, 95%CI=1.153--36.404, *P*=0.034), coma on admission was associated with short OS (aHR=9.808, 95%CI=2.802--34.323, *P*=0.000) and SFS (aHR=5.841, 95%CI=2.652--12.864, *P*=0.000), non-adjuvant steroid therapy was associated with short OS (aHR=4.768 95%CI=1.946--11.678, *P*=0.001), and septic shock on admission was associated with poor SFS (aHR=2.949, 95%CI=1.049--8.290, *P*=0.040). Our results were similar to previous reports.[@CIT0016],[@CIT0017],[@CIT0025],[@CIT0026] According to previous evidence, the CSF of PM patients usually shows aberrant WBC count, protein level, and glucose level, thus we also analyzed the prognostic value of WBCs in blood or CSF, protein in CSF, and glucose in CSF to predict complications, OS, and SFS in pediatric PM patients. Our result suggested that lower WBCs in blood was an independent predictive factor of complications and lower glucose level in CSF was an independent prognostic factor of poor SFS. Leukopenia is reflective of severe sepsis, and lower peripheral blood and CSF WBC counts may indicate inadequacy of the immune response. Chao et al also found an association between lower WBCs in CSF and higher mortality in PM[@CIT0019] Lower glucose levels in the CSF is correlated with increased inflammation and cytokine levels[@CIT0035] and the inflammatory response is implicated in the pathogenesis of PM and associated brain injury and neuronal death, via releasing potentially cytotoxic agents such as ROS and proteolytic enzymes by leucocytes recruited during the inflammatory response[@CIT0036] A lower glucose level in CSF can indicate increased central nervous system inflammation, which is expected to result in a higher risk of neurological sequelae and poor SFS in PM patients. High protein levels in CSF are related to more severe inflammatory reactions and immune responses during bacterial meningitis,[@CIT0037],[@CIT0038] and may also be a predictor of later poor outcomes in PM patients, although we only observed an association between protein level in CSF and OS in univariate analysis.

This study is the most comprehensive nationwide, multi-centric study on pediatric PM in mainland China up to date. However, some limitations still existed in our study. Firstly, information on capsular serotyping of the pediatric PM patients in our retrospective study was not available and the associations of serotype distribution with clinical outcomes of the patients were not clear. Secondly, although pneumococcal vaccines have been licensed in mainland China, none of the patients in our study received pneumococcal vaccination, which might also be associated with prognosis in PM patients.

Conclusion {#S0005}
==========

Our study showed that PM is a disease with high mortality and neurological sequelae in pediatric patients, and complications during the clinical course occur frequently. In pediatric PM patients, age less than 28 months and lower WBCs in blood were independent predictive factors for complications; age less than 28 months, coma, and non-adjuvant steroid therapy were independent prognostic factors for poor OS; and coma, septic shock on admission, and lower glucose level in CSF were independent prognostic factors for poor SFS.
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[^1]: **Notes:** ^a^Predisposing diseases were defined as previous head trauma, history of intracranial surgery, dura disruption, ear or intracranial abnormalities etc. ^b^Intracranial surgery (ventriculostomy, cochlear implantation, ventriculoperitoneal shunt, removal of lateral ventricular reservoir sac, cranioplasty, etc.)

    **Abbreviations:** PM, pneumococcal meningitis; IQR, interquartile range; CSF, cerebrospinal fluid; WBC, white blood cell.

[^2]: **Notes:** ^a^Data are numbers (%). Percentages are calculated per number of episodes with cranial CT or MRI undertaken. ^b^Numbers do not add up to totals because of the presence of multiple abnormalities in several patients. ^c^Middle ear malformation in three, pneumocephalus in two, meningioma in one, and cerebral vascular malformation in one.

[^3]: **Note:** Bold, indicates *P*\<0.05.

    **Abbreviations:** PM, pneumococcal meningitis; MODS, multiple organ dysfunction syndrome; CSF, cerebrospinal fluid; WBC, white blood cell.

[^4]: **Note:** Bold, indicates *P*\<0.05.

    **Abbreviations:** PM, pneumococcal meningitis; WBC, white blood cell.

[^5]: **Note:** Bold, indicates *P*\<0.05.

    **Abbreviations:** OS, overall survivalPM, pneumococcal meningitis; MODS, multiple organ dysfunction syndrome; CSF, cerebrospinal fluid; WBC, white blood cell.

[^6]: **Note:** Bold, indicates *P*\<0.05.

    **Abbreviations:** SFS, sequelae-free survival; PM, pneumococcal meningitis; MODS, multiple organ dysfunction syndrome; CSF, cerebrospinal fluid; WBC, white blood cell.
